Articles with "cd22 dual" as a keyword



Photo by kimsuzi08 from unsplash

Successful 24-Hours Manufacture of Anti-CD19/CD22 Dual Chimeric Antigen Receptor (CAR) T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Sign Up to like & get
recommendations!
Published in 2020 at "Blood"

DOI: 10.1182/blood-2020-136866

Abstract: Introduction Multiple issues arise for a wider application of chimeric antigen receptor (CAR) T cell therapy including manufacturing time and antigen escape. Here we report data on an anti-CD19/CD22 dual CAR-T (GC022F) therapy based on… read more here.

Keywords: cd19 cd22; gracell biotechnologies; biotechnologies ltd; cd22 dual ... See more keywords